Biomea Fusion

Biomea Fusion, based in Redwood City, CA, is a clinical-stage biopharmaceutical company dedicated to revolutionizing medicine through the development of novel covalent small molecules aimed at curing serious and life-threatening diseases. With a focus on diabetes and obesity, the company has established a robust research and development engine that has produced multiple inhibitor programs currently in preclinical and clinical stages.

All of Biomea Fusion's drug candidates are invented and created in-house, showcasing their commitment to highly selective, targeted medicines that address critical mechanisms of disease progression. The company's team is actively involved in all phases of drug discovery and development, from target selection to clinical studies, to bring innovative therapies to patients in need.

Generated from the website